They stain and analyze body cells under the microscope for changes that indicate cancer or infection. A minimum of 2.5 GPA on the pre-clinical academic program is required for students to be considered for cytotechnology training at an affiliated hospital. Applicants for the final year of cytotechnology training must apply for transcript review by the Clinical Laboratory Sciences Department between January 1 and March 1 the same year. Complete applications and transcript evaluations of qualified applicants are supplied to the respective hospital schools by the CLS Department. Students are then selected to fill available positions by the joint admissions committee on the basis of Grade Point Average, personal interview, and student academic status at Marshall.
Last preference is given to qualified applicants or graduates from other colleges and universities.
A waiting list is established using these criteria in case an opening becomes available. Admitted students will be required to attend an instructional program on blood borne pathogens and either begin the Hepatitis B vaccine series or sign a waiver form refusing it. They are also required to provide other health documentation, including tuberculosis test results and proof of health insurance. Successful completion of the pre-clinical academic program does not automatically assure admission to clinical studies, since enrollment at the associated hospitals is limited. These charges may change.